Susan Stein, CEO, Connexion Healthcare, Appointed to the Board of Directors of Global Genes
NEWTOWN, Pa., June 17, 2015 /PRNewswire/ -- Susan C. Stein, MPH, CEO of the award-winning Connexion Healthcare, has been appointed to the Board of Directors of Global Genes™, a leading patient advocacy organization in the Rare Disease community. "Global Genes is dedicated to improving the future of patients with rare diseases and their families. Susan's experience will be invaluable as we work to achieve this critical objective," said Nicole Boice, Founder & CEO of Global Genes.
Connexion Healthcare, a full-service provider of medical and scientific communications, serves the world's leading pharmaceutical, biotech, and medical device companies through its 2 Centers of Excellence—Oncology and Rare Disease. "Building awareness and educating health care professionals about rare disease is at the core of Connexion Healthcare's services. It is part of our mission and aligns perfectly with the Global Genes mission of eliminating the challenges of patients with rare disease. Connexion Healthcare has been committed to assisting Global Genes with this important mission. We look forward to continuing the relationship and having an even greater impact on patient outcomes," said Susan Stein.
Ms Stein has built Connexion Healthcare into one of Philadelphia Business Journal's top 25 women-owned businesses. Connexion Healthcare has been certified as a Women's Business Enterprise by the Women's Business Development Center of Philadelphia. PharmaVoice included Ms Stein among its "Top 100 Most Inspiring People in the Life Sciences Industry," and she was honored by the Philadelphia Business Journal as one of the "Women of Distinction." Medical Marketing & Media (MM&M) recognized her as a finalist for Agency Marketer of the Year in 2014. Ms Stein received her Master's degree from the Drexel University School of Public Health in Philadelphia, PA, where she serves on the Dean's Advisory Council.
About Global Genes
Begun as a grassroots movement in 2009, Global Genes™ is a nonprofit patient advocacy organization that has since grown to more than 500 global organizations with the mission of eliminating the challenges of rare diseases through awareness, outreach, education, and collaborative partnerships.
CONTACT: Colleen Harrison, 215-944-9432, [email protected]
SOURCE Connexion Healthcare
Share this article